Testing a mobile PET-CT scanner to check tumor edges during surgery
Tests a mobile PET-CT scanner to check tumor edges in oral cancer and sarcoma surgery.
Plain-language title generated from the registry record
Registry title: Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
Key facts
- Where
- Groningen, NetherlandsSee the site
Where in Netherlands
- University Medical Center GroningenGroningen, NetherlandsNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Groningen
- Trial code
- NCT06726512
- Record updated
- 10 December 2024
- Original description
The primary endpoint is the assessment of the clinical value of a novel high-resolution mobile PET-CT scanner for intraoperative margin assessment in oral squamous cell carcinoma, soft tissue sarcoma and osteosarcoma surgery. The predicted margin status will be correlated with the margin status determined with histopathology.Read full original descriptionShow less
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
The primary endpoint is the assessment of the clinical value of a novel high-resolution mobile PET-CT scanner for intraoperative margin assessment in oral squamous cell carcinoma, soft tissue sarcoma and osteosarcoma surgery. The predicted margin status will be correlated with the margin status determined with histopathology.
Inclusion: Age ≥18 years; Patient is confirmed with oral squamous cell carcinoma, soft tissue sarcoma or osteosarcoma; Patient is indicated to undergo curative surgery of the primary tumor; Patient is estimated compliant for study participation by the investigator; Written informed consent.
Exclusion: Patient has previously received radiotherapy of the primary tumor region; Patient has participated in other clinical studies with radiation exposure of more than 1 mSv in the past 12 months; Medical or psychiatric conditions that compromise the patient's ability to give informed consent; A blood glucose level over 200 mg/dL on the day of surgery; Pregnancy or lactation.